These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3896612)

  • 41. Intravenous cyclosporine and kidney function: the Johns Hopkins experience.
    Williams GM; Irwin B; Burdick J; Pennington L
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):66-8. PubMed ID: 3515697
    [No Abstract]   [Full Text] [Related]  

  • 42. Parallel blood concentrations of second-generation cyclosporine metabolites and bilirubin in liver graft recipients.
    Christians U; Kohlhaw K; Sürig T; Bader A; Schottmann R; Linck A; Ringe B; Sewing KF
    Ther Drug Monit; 1995 Oct; 17(5):487-98. PubMed ID: 8585112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pharmacokinetics of cyclosporine and its metabolites in patients undergoing kidney transplantation].
    Silva Junior HT; Pereira AB; Ajzen H; Bueno V; Pestana JO
    Rev Assoc Med Bras (1992); 1994; 40(3):159-71. PubMed ID: 7787866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Population pharmacokinetics of sirolimus in kidney transplant patients.
    Ferron GM; Mishina EV; Zimmerman JJ; Jusko WJ
    Clin Pharmacol Ther; 1997 Apr; 61(4):416-28. PubMed ID: 9129559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of mode of pretransplant loading with cyclosporine on the incidence of early rejection in haploidentical living related donor renal recipients.
    Kahan BD; Wideman C; Gibbons S; Ried M; Jarowenko M; Flechner S; Van Buren CT
    Transplant Proc; 1984 Dec; 16(6):1619-23. PubMed ID: 6390876
    [No Abstract]   [Full Text] [Related]  

  • 46. The pharmacokinetics and colonic tissue concentrations of cyclosporine after i.v., oral, and enema administration.
    Sandborn WJ; Strong RM; Forland SC; Chase RE; Cutler RE
    J Clin Pharmacol; 1991 Jan; 31(1):76-80. PubMed ID: 2045532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclosporine metabolite disposition after oral administration in pretransplant end-stage renal disease patients.
    Alexander DP; Horning L; Bowers LD
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):499-508. PubMed ID: 3284097
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclosporine.
    Ptachcinski RJ; Burckart GJ; Venkataramanan R
    Drug Intell Clin Pharm; 1985 Feb; 19(2):90-100. PubMed ID: 3882378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of oral and intravenous cyclosporine A in kidney transplants.
    Asokan VS; Sweny P; Varghese Z; Moorhead JF; Fernando ON
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1717-8. PubMed ID: 3274412
    [No Abstract]   [Full Text] [Related]  

  • 50. Cyclosporine pharmacokinetics in nephrotic and kidney-transplanted children.
    Jacqz-Aigrain E; Montes C; Brun P; Loirat C
    Eur J Clin Pharmacol; 1994; 47(1):61-5. PubMed ID: 7988626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclosporine (cyclosporin A) pharmacokinetics in renal transplant patients receiving ciprofloxacin.
    Lang J; Finaz de Villaine J; Garraffo R; Touraine JL
    Am J Med; 1989 Nov; 87(5A):82S-85S. PubMed ID: 2589391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of dietary fat on the pharmacokinetics and pharmacodynamics of cyclosporine in kidney transplant recipients.
    Tan KK; Trull AK; Uttridge JA; Metcalfe S; Heyes CS; Facey S; Evans DB
    Clin Pharmacol Ther; 1995 Apr; 57(4):425-33. PubMed ID: 7712671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice.
    Ducharme MP; Warbasse LH; Edwards DJ
    Clin Pharmacol Ther; 1995 May; 57(5):485-91. PubMed ID: 7768070
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjects.
    Grevel J; Nüesch E; Abisch E; Kutz K
    Eur J Clin Pharmacol; 1986; 31(2):211-6. PubMed ID: 3803418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures.
    Brunette KE; Anderson BJ; Thomas J; Wiesner L; Herd DW; Schulein S
    Paediatr Anaesth; 2011 Jun; 21(6):653-62. PubMed ID: 21355949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.
    Lindholm A; Dahlqvist R; Groth GG; Sjöqvist F
    Br J Clin Pharmacol; 1990 Sep; 30(3):443-52. PubMed ID: 2223423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isosorbide dinitrate kinetics and dynamics after intravenous, sublingual, and percutaneous dosing in angina.
    Morrison RA; Wiegand UW; Jähnchen E; Höhmann D; Bechtold H; Meinertz T; Fung HL
    Clin Pharmacol Ther; 1983 Jun; 33(6):747-56. PubMed ID: 6851405
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclosporine immunosuppression.
    Canafax DM; Ascher NL
    Clin Pharm; 1983; 2(6):515-24. PubMed ID: 6360494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclosporine pharmacokinetic profiles in liver, heart, and kidney transplant patients as determined by high-performance liquid chromatography.
    Burckart GJ; Venkataramanan R; Ptachcinski RJ; Starzl TE; Griffith BP; Hakala TR; Rosenthal JT; Hardesty RL; Iwatsuki S; Brady J
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):129-36. PubMed ID: 3538565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Absorption and disposition of SDZ IMM 125, a new cyclosporine derivative, in rats after single and repeated administration.
    Bruelisauer A; Kawai R; Misslin P; Lemaire M
    Drug Metab Dispos; 1994; 22(2):194-9. PubMed ID: 8013274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.